Mefenamic Acid
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Mefenamic Acid is used to treat dysmenorrhea, fever, menorrhagia and premenstrual syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Nov 19, 2010. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $72K on Mefenamic Acid across 320 claims for 175 beneficiaries.
Mefenamic Acid is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $0.95 to $0.95 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$0.95 – $0.95
per EA
7d Activity
avg +1.6% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Micro Labs Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonsteroidal Anti-inflammatory Drug class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing MEFENAMIC ACID
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MEFENAMIC ACID 250 MG CAPSULE | $0.9479 per EA | +1.56% |
MEFENAMIC ACID 250 MG CAPSULE | $0.9479 per EA | +1.56% |
Frequently Asked Questions
What is Mefenamic Acid used to treat?
Mefenamic Acid is used to treat dysmenorrhea, fever, menorrhagia and premenstrual syndrome, per the National Library of Medicine's MED-RT classification.
When did Mefenamic Acid become available as a generic?
FDA approved the first generic Mefenamic Acid (ANDA) on Nov 19, 2010. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Mefenamic Acid?
In 2024, Medicare Part D spent $72K on Mefenamic Acid across 320 claims for 175 beneficiaries.
How many Mefenamic Acid products are on the market?
The Mefenamic Acid drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Mefenamic Acid?
NADAC reference prices for Mefenamic Acid range from $0.9479 to $0.9479 per EA.
Which manufacturers make Mefenamic Acid?
2 manufacturers list Mefenamic Acid in NADAC. Ranked by number of NDCs, the largest are Micro Labs Limited (1), Lupin Pharmaceuticals Inc. (1).
How has the price of Mefenamic Acid changed recently?
Over the past 7 days, 2 Mefenamic Acid NDCs rose and 0 fell, with a market-wide average change of +1.6%.